137 related articles for article (PubMed ID: 21239998)
1. CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells.
Franco D; Liu W; Gardiner DF; Hahn BH; Ho DD
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):393-400. PubMed ID: 21239998
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.
Zhang R; Zhang S; Li M; Chen C; Yao Q
Vaccine; 2010 Jul; 28(31):5114-27. PubMed ID: 20471443
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
Gupta S; Termini JM; Raffa FN; Williams CA; Kornbluth RS; Stone GW
J Virol; 2014 Feb; 88(3):1492-501. PubMed ID: 24227853
[TBL] [Abstract][Full Text] [Related]
5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-like particles activate multiple types of immune cells.
Sailaja G; Skountzou I; Quan FS; Compans RW; Kang SM
Virology; 2007 Jun; 362(2):331-41. PubMed ID: 17276476
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
8. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.
Wong SB; Siliciano RF
J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195
[TBL] [Abstract][Full Text] [Related]
9. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.
Liu J; Yu Q; Stone GW; Yue FY; Ngai N; Jones RB; Kornbluth RS; Ostrowski MA
Vaccine; 2008 Jul; 26(32):4062-72. PubMed ID: 18562053
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
Flamar AL; Bonnabau H; Zurawski S; Lacabaratz C; Montes M; Richert L; Wiedemann A; Galmin L; Weiss D; Cristillo A; Hudacik L; Salazar A; Peltekian C; Thiebaut R; Zurawski G; Levy Y
PLoS One; 2018; 13(11):e0207794. PubMed ID: 30500852
[TBL] [Abstract][Full Text] [Related]
11. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.
Aline F; Brand D; Pierre J; Roingeard P; Séverine M; Verrier B; Dimier-Poisson I
Vaccine; 2009 Aug; 27(38):5284-91. PubMed ID: 19450633
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.
Smed-Sörensen A; Loré K; Walther-Jallow L; Andersson J; Spetz AL
Blood; 2004 Nov; 104(9):2810-7. PubMed ID: 15231570
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
Ao Z; Wang L; Mendoza EJ; Cheng K; Zhu W; Cohen EA; Fowke K; Qiu X; Kobinger G; Yao X
PLoS One; 2019; 14(5):e0216949. PubMed ID: 31100082
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
17. A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.
Melchers M; Matthews K; de Vries RP; Eggink D; van Montfort T; Bontjer I; van de Sandt C; David K; Berkhout B; Moore JP; Sanders RW
Retrovirology; 2011 Jun; 8():48. PubMed ID: 21689404
[TBL] [Abstract][Full Text] [Related]
18. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.
Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP
Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoke exposure promotes differentiation of CD4
Liang Y; Shen Y; Kuang L; Zhou G; Zhang L; Zhong X; Zhang J; Liu J
Int J Chron Obstruct Pulmon Dis; 2018; 13():959-968. PubMed ID: 29606863
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
Akahata W; Yang ZY; Nabel GJ
J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
